Impact of chemotherapy on primary colon cancer
Sign Up to like & getrecommendations! Published in 2020 at "Techniques in Coloproctology"
DOI: 10.1007/s10151-020-02365-9
Abstract: A 65-year-old female with asymptomatic sigmoid colon cancer and synchronous multiple liver metastases achieved complete clinical response of both disease sites following 22 cycles of oxaliplatin chemotherapy at colonoscopy and computed tomography scan, respectively (Fig.… read more here.
Keywords: impact chemotherapy; primary colon; colon cancer; chemotherapy primary ... See more keywords
Colorectal Metastasis from Ovarian Neoplasm Mimicking Primary Colon Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Case Reports in Gastroenterology"
DOI: 10.1159/000510934
Abstract: Metastasis to the colon from another primary internal malignancy is an untypical and a seldom reported entity. Direct visualization during colonoscopy is considered the gold standard of diagnosis. Pathologic diagnosis with immunohistochemical staining is essential… read more here.
Keywords: primary colon; colon; metastasis; colon cancer ... See more keywords
A colonic metastasis from extrahepatic cholangiocarcinoma after removal of primary tumor: a case report and literature review.
Sign Up to like & getrecommendations! Published in 2020 at "Chinese clinical oncology"
DOI: 10.21037/cco.2020.01.08
Abstract: Metastatic cholangiocarcinoma (CCA) to the gastrointestinal tracts has rarely been described in the literature. We report a 54-year-old male patient with radical resection of an extrahepatic CCA who underwent uncommon metastatic pattern. After a recurrence-free… read more here.
Keywords: literature; cholangiocarcinoma; primary colon; colon ... See more keywords
Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.969855
Abstract: Background Mesenchymal Consensus Molecular Subtype 4 (CMS4) colon cancer is associated with poor prognosis and therapy resistance. In this proof-of-concept study, we assessed whether a rationally chosen drug could mitigate the distinguishing molecular features of… read more here.
Keywords: imatinib; cms4; colon cancer; primary colon ... See more keywords